[go: up one dir, main page]

UA81199U - Method for integrated therapy of comorbid alcohol and smoking addiction - Google Patents

Method for integrated therapy of comorbid alcohol and smoking addiction

Info

Publication number
UA81199U
UA81199U UAU201214622U UAU201214622U UA81199U UA 81199 U UA81199 U UA 81199U UA U201214622 U UAU201214622 U UA U201214622U UA U201214622 U UAU201214622 U UA U201214622U UA 81199 U UA81199 U UA 81199U
Authority
UA
Ukraine
Prior art keywords
smoking addiction
integrated therapy
dose
comorbid
alcohol
Prior art date
Application number
UAU201214622U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Иван Кузьмич Сосин
Галина Николаевна Мисько
Елена Юрьевна Гончарова
Юрий Федорович Чуев
Виктория Алексеевна Шаповалова
Валерий Владимирович Шаповалов
Алексей Викторович Киосев
Валентин Валерьевич Шаповалов
Владимир Александрович Скобелев
Александр Анатольевич Осипов
Иван Михайлович Сквыра
Original Assignee
Харьковская Медицинская Академия Последипломного Образования
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харьковская Медицинская Академия Последипломного Образования filed Critical Харьковская Медицинская Академия Последипломного Образования
Priority to UAU201214622U priority Critical patent/UA81199U/en
Publication of UA81199U publication Critical patent/UA81199U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for the integrated therapy of comorbid alcohol and smoking addiction provides for the use of Adaptol (Mebicar) as tranquilizer per os at a dose of 0.3- 2-3 times a day, Carbamasepin as anticonvulsant-thymoleptic at a daily dose 0.05- , and Noofen (Phenibut) tranquilizer possessing antyhypoxic and antiamnestic activities at a dose 0.25- thrice a day, the duration of the treatment is 10-14 days.
UAU201214622U 2012-12-20 2012-12-20 Method for integrated therapy of comorbid alcohol and smoking addiction UA81199U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201214622U UA81199U (en) 2012-12-20 2012-12-20 Method for integrated therapy of comorbid alcohol and smoking addiction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201214622U UA81199U (en) 2012-12-20 2012-12-20 Method for integrated therapy of comorbid alcohol and smoking addiction

Publications (1)

Publication Number Publication Date
UA81199U true UA81199U (en) 2013-06-25

Family

ID=51947918

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201214622U UA81199U (en) 2012-12-20 2012-12-20 Method for integrated therapy of comorbid alcohol and smoking addiction

Country Status (1)

Country Link
UA (1) UA81199U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2739192C1 (en) * 2020-06-18 2020-12-21 федеральное государственное бюджетное образовательное учреждение высшего образования «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО ОмГМУ Минздрава России) Method of treating abstinence syndrome, in order to prevent developing psychosis, in individuals with dependence on synthetic agonists of gamma-aminobutyric acid receptors: butyrolactone, 1,4-butanediol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2739192C1 (en) * 2020-06-18 2020-12-21 федеральное государственное бюджетное образовательное учреждение высшего образования «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО ОмГМУ Минздрава России) Method of treating abstinence syndrome, in order to prevent developing psychosis, in individuals with dependence on synthetic agonists of gamma-aminobutyric acid receptors: butyrolactone, 1,4-butanediol

Similar Documents

Publication Publication Date Title
EA201991484A1 (en) MEDICINAL FORMS OF ENZALUTAMIDE
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
MX2020004023A (en) Use of a pcsk9 inhibitor to treat hyperlipidemia.
AU2011328009A8 (en) Compounds and methods for treating pain
MX366130B (en) Bivalent inhibitors of iap proteins and therapeutic methods using the same.
EA201492040A1 (en) BICYCLICALLY SUBSTITUTED URACILES AND THEIR APPLICATION
NZ630367A (en) Methods of treatment of pediatric solid tumor
EA201390745A1 (en) THE USER-ACTIVATED AUTONOMOUS PERFORMED IN A SINGLE CASE A SYSTEM OF DELIVERY OF MEDICINES BY MEANS OF IONOPHORESIS
WO2014028668A3 (en) Stem cell enhancing therapeutics
MX2015011905A (en) Use of levocetirizine and montelukast in the treatment of vasculitis.
IN2014DN09238A (en)
UA107204C2 (en) ANTI-FUNCTIONAL COMPOSITION CONTAINING THE PYTHIUM OLIGANDRUM Fungal Organism
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
MX367393B (en) ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SKIN and NAILS.
MX2015013155A (en) Tetrandrine family pharmaceutical formulations and method.
PH12018550008A1 (en) Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
UA81199U (en) Method for integrated therapy of comorbid alcohol and smoking addiction
GB201006042D0 (en) Improvements in or relating to organic compounds
EA201491629A1 (en) METHODS OF TREATMENT CANCER USING LIPOPLATIN
UA70710U (en) Method for preventing recurrence of allergodermatosis in patients with secondary immunodeficiencies
GEP20196947B (en) Bremelanotide therapy for female sexual dysfunction
UA84197U (en) Method for medical rehabilitation of patients with irritated bowel syndrome combined with neurocirculatory dystonia
UA69428U (en) Method for treating diabetic retinopathy
UA64165U (en) Method for treating patients with injuries of soft tissues in limbs
UA91458U (en) Method for correcting activity of enzymes in blood of fowl in treatment of eimeriosis